Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Billionaire Israel Englander is the founder and CEO of Millennium Management, the second-most profitable hedge fund in ...

CEO Alex Karp took a victory lap following his company's most recent earnings, saying the results were so strong that "I ...

Jefferies has an Underperform rating on Palantir and a price target of $28; PLTR shares are changing hands for $62.2 in Tuesday's early market trading. This article first appeared on GuruFocus.

"CEO Alex Karp has sold nearly 40M shares of PLTR for an aggregate of more than $1.9B over the last 3 months, and more than 18M shares for an aggregate of more than $1B just over the last 2 weeks.

However, that has taken the stock to a stratospheric valuation. I would follow CEO Alex Karp's lead and take some profits. Palantir's stock has been a huge winner this year. CEO Alex Karp took a ...

After all, X CEO has played an outsized role in his comeback ... Palantir Technologies Inc. (NYSE:PLTR) provides data-driven solutions with its AI Platform (AIP) for testing, debugging code ...

Brent Thill, an analyst from Jefferies, maintained the Sell rating on Palantir Technologies (PLTR – Research Report ... particularly by the CEO, who has sold a substantial portion of his ...

PLTR) stands against the other AI stocks that are making waves right now. With Donald Trump having won the elections, it seems Elon Musk is going to be a powerful force in the administration. After ...